Kane Biotech Partners with Marathon Medical to Enter U.S. Veterans Affairs Market
Kane Biotech Inc. expands its U.S. commercialization strategy through a distribution partnership with Marathon Medical Corporation. This agreement targets the U.S. Veterans Affairs, Department of Defense, and Indian Health Services markets, supporting the growth of Kane's advanced wound care portfolio, including the revyve® Antimicrobial Wound Gel. Additionally, Kane is establishing a contract-based sales team to enhance its national presence.
Theia Market Signal Identification - AI Assisted
Kane Biotech Inc. has signed a distribution agreement with Marathon Medical Corporation to aid its entry into the U.S. Veterans Affairs, Department of Defense, and Indian Health Services markets. The partnership leverages Marathon's position as a leading medical supply distributor with extensive federal procurement contracts.
Kane is also building a contract-based sales team across the U.S. to strengthen its national sales network for the revyve product line. These initiatives are part of Kane's strategy to create a scalable U.S. distribution infrastructure for its advanced wound care solutions.
Comments